COMP <GO>
CPRI vs CRI // EV/EBITDA & P/E VALUATION
Capri Holdings Limited (NYSE) VS. Carter's Inc. (NYSE) • 15-METRIC TALLY: CPRI 4
— CRI 9
▲ EV/EBITDA & P/E VALUATION LEADER: CRI
LAST: $16.06 (+5.04%) • MKT CAP: $1.83B
valuation
24.8x
LAST: $33.38 (+7.54%) • MKT CAP: $1.23B
valuation
6.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPRI VS. CRI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPRI | CRI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.30% | 45.40% | +16.90 | CPRI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.40% | 11.30% | -0.90 | CRI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 24.8x | 6.9x | +17.90 | CRI | /valuation <GO> |
| Free Cash Flow Yield | 0.77% | 5.60% | -4.83 | CRI | /fcf-yield <GO> |
| Operating Margin | 0.70% | 5.00% | -4.30 | CRI | /operating-margins <GO> |
| Net Profit Margin | 2.30% | 3.20% | -0.90 | CRI | /net-margins <GO> |
| Revenue Growth (YoY) | -4.10% | 1.90% | -6.00 | CRI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 4.60% | -4.60 | CRI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.32 | 2.63 | +0.69 | CPRI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | CRI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.3 | 47.1 | +26.21 | CPRI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.5x | 12.4x | +9.10 | CRI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.83B | $1.23B | $599.8M | CPRI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPRI REV | CRI REV | CPRI GROSS % | CRI GROSS % | CPRI FCF | CRI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.47B | $2.90B | 62.3% | 45.4% | $14.0M | $68.6M |
| FY 2024 | $3.62B | $2.84B | 62.2% | 48.0% | $207.0M | $242.6M |
| FY 2023 | $4.14B | $2.95B | — | — | $309.0M | $529.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPRI // BETA —
CRI // BETA —